Omacor - Newsfeeds

UK heart patients to get omega-3 on prescription?: Nutra Ingredients - For patients who have had an MI within 3 months and who are not achieving 7 g of omega 3 fatty acids per week, consider providing at least 1 g daily of omega-3-acid ethyl esters treatment licensed for secondary prevention post MI for up to 4 years," ...
Reliant Pharmaceuticals Names Bradley T. Sheares, Ph.D. Chief ...: Phramalive.com - Brad has the scientific expertise, commercialization experience, and vision to guide Reliant and realize the full potential of the company's lead product, Omacor(R) (omega-3 acid ethyl esters), and our pipeline. On behalf of the Board of Directors, I ...
Reliant Pharmaceuticals Submits New Data To FDA Supporting Use Of ...: Medical News Today - Reliant Pharmaceuticals today announced a submission to the U.S. Food and Drug Administration (FDA) to seek approval for the expanded use of Omacor(R) (omega-3-acid ethyl esters) as an adjunct to diet and statin therapy in adults whose triglyceride ...
Reliant Pharmaceuticals Submits New Data to FDA Supporting Use of ...: PR Newswire - LIBERTY CORNER, N.J., Dec. 13 /PRNewswire/ -- Reliant Pharmaceuticals today announced a submission to the U.S. Food and Drug Administration (FDA) to seek approval for the expanded use of Omacor(R) (omega-3-acid ethyl esters) as an adjunct to diet and ...
Authors: Michael Miller, MD; Christie M. Ballantyne, MD: Medscape News - ... because traditional over-the-counter preparations generally contain 30% of active EPA/DHA compound, up to 6 or more capsules must be ingested daily to attain appreciable TG lowering. [10] "Recently, a more potent preparation, omega-3 acid ethyl esters ...
New Data Demonstrates Minimal Interactions Between Omacor(R) (Omega-3 ...: PR Newswire - LIBERTY CORNER, N.J., Aug. 17 /PRNewswire/ -- Reliant Pharmaceuticals today announced the publication of new data in the July edition of the Journal of Clinical Pharmacology finding the co-administration of Omacor (omega-3-acid ethyl esters) with ...
New Data Demonstrates Minimal Interactions Between Omacor (Omega-3 ...: Phramalive.com - LIBERTY CORNER, N.J., August 17, 2006 /PRNewswire/ -- Reliant Pharmaceuticals today announced the publication of new data in the July edition of the Journal of Clinical Pharmacology finding the co-administration of Omacor (omega-3-acid ethyl esters ...

Pronova BioPharma cuts shipment outlook for partner demand in 2010: GSK, as a part of its Operational Excellence Programme, will reduce inventory levels of Omacor/Lovaza and consequently, Pronova BioPharma has revised its full year 2010 outlook on partner demand to 1,600 tonnes - 1,700 ...
GlaxoSmithKline to acquire Reliant Pharmaceuticals: Through its strategic in-licensing and development strategy, Reliant has developed a portfolio of specialty medicines combating heart disease, including US rights to Lovaza(TM) (omega-3-acid ethyl esters), a treatment for adult patients with very ...
GSK to Acquire Reliant Pharmaceuticals for $1.65B: Through its strategic in-licensing and development strategy, Reliant has developed a portfolio of specialty medicines combating heart disease including U.S. rights to Lovaza™ (omega-3-acid ethyl esters), a treatment for adult patients with very ...
New Data Shows Prescription Omega-3 Acid Ethyl Esters Reduced the ...: PHILADELPHIA, Sept. 4 /PRNewswire/ -- Results from a new international study, the GISSI Heart Failure (GISSI-HF) study, showed that 1 g/d dose of omega-3 acid ethyl esters reduced all cause mortality and hospital admissions for cardiovascular reasons ...
Pronova BioPharma Norge AS files lawsuit against Teva Pharmaceuticals ...: ... to Pronova BioPharma advising that Teva USA has submitted an Abbreviated New Drug Application to the FDA seeking approval to engage in the commercial manufacture, use, or sale of generic versions of Pronova Bio Pharma’s omega-3-acid ethyl esters ...
Pronova BioPharma files lawsuit against Teva Pharmaceuticals: ... to Pronova BioPharma advising that Teva USA has submitted an abbreviated new drug application to the FDA seeking approval to engage in the commercial manufacture, use, or sale of generic versions of Pronova BioPharma's omega-3-acid ethyl esters ...
Pronova BioPharma ASA (NO) - Maintaining operational momentum: ... in the United States District Court for the District of Delaware asserting infringement of Pronova BioPharma's US Patents Nos. 5 502 077 and 5 656 667 relating to omega-3 acid ethyl ester compositions and methods of using omega-3 acid ethyl esters ...

Looking for a District of Columbia Omacor attorney? Get in touch with one of our District of Columbia Omacor attorneys now.

Content provided by MSN. LegalView is not responsible for the accuracy of the information provided above.

Need An Omacor Attorney?

First Name Last Name Email Address State

Legal Issue

DrugWatch: Omacor Click to select a Legal Issue

Has Your Health Been Negatively Affected?

Please Describe the Injury

Click to Ask a Question

close this window

Omacor Information

Click to View Our Legal Resources

Looking for a District of Columbia Omacor attorney? Get in touch with one of our District of Columbia Omacor attorneys now.

Close (x)

Looking for an Attorney?

Please type your question:

First Name:
Last Name:
E-mail:
Phone Number *
() -

State * Legal Issue *

DrugWatch: Omacor Click to select a Legal Issue

Close (x)

Find Legal Help for Your Omacor Case - Submit Your Information Below

Do you need legal assistance with your Omacor case?
LegalView may be able to help.

Submit your information below for a free, no-cost evaluation.

We'll submit your information to one of our partner firms.
LegalView's partners represent clients throughout the United States, for a very wide range of legal issues. Submit your information now, to see if one of LegalView's partners can help!

* Indicates Required Fields

First name *

Last name *

Email Address *

Phone Number *
() -

State *

Legal Issue * DrugWatch: Omacor Change

Was There an Injury?

Please Describe The Injury

Please State Your Question *

DISCLAIMER and STATEMENT OF NON-CONFIDENTIALITY

By submitting this form, you agree that completing the above is not intended to create an attorney-client relationship.

Disclosure

Legal WebTV Network LLC, LegalView.com, and LegalWebMedia.com are group advertising sponsored by the attorneys identified here. It is not a lawyer referral service. If you submit information on this website, LegalWebMedia.com will submit your information to the law firms that pay for this group advertising and to respond to your requests for information concerning legal services in their assigned local areas. If there is no sponsoring firm in your state, your inquiry will be submitted to one of the sponsoring law firms on a predetermined, rotating basis. If the sponsoring law firm accepts your case, it will associate with licensed attorneys practicing in your state, if required; the sponsoring law firm may also contact other law firms to see if they may be able to assist.

The information provided by the LegalView.com and LegalWebMedia.com websites is for advertising and informational purposes and should not be considered as legal advice from the sponsoring attorneys. The websites contain general information and may not reflect current legal developments, verdicts, or settlements. LegalView.com contains information created by others or supplied through open forums; the sponsoring law firms are not responsible for the accuracy of this information. Any person viewing or receiving information from these websites should not act or refrain from acting on the basis of any such information without first seeking appropriate legal advice from an attorney in your area. Legal WebTV Network, LLC expressly disclaims any liability with respect to actions taken or not taken by the recipient based on any or all of the information or contents contained in these websites.

Any information sent to Legal WebTV Network LLC through this website is done using standard Web encryption techology. LegalView.com will exercise all reasonable care, within technological limits, to protect the confidentiality of any information submitted via Internet e-mail or through this website. By accessing this website, you may be seeking an attorney to represent you or legal advice. However, none of the sponsoring attorneys represent you yet.

The choice of a lawyer is an important decision and should not be based solely upon advertisements.

Any transmission of information, whether via Internet e-mail or through the website, is solely for evaluation purposes by the sponsoring law firms and their associates. The transmission of any information to any attorney sponsoring advertising on LegalView.com or LegalWebMedia.com does not create an attorney-client relationship between the sender and any recipient. An attorney-client relationship can only be created by a written, signed-fee agreement entered into with an attorney. The sponsoring attorneys will treat your information as a confidential communication for the purpose of obtaining legal services or legal advice.

For more information about the sponsoring law firms, please click here.

This form is secure and encrypted. More information about secure forms and your privacy here.